CPT® Code 87320

1. Indications

The procedure associated with CPT® Code 87320 is indicated for the detection of Chlamydia trachomatis in patients who may be at risk for this sexually transmitted infection. The following conditions and symptoms warrant the use of this immunoassay technique:

• Asymptomatic Screening Individuals who are asymptomatic but are at risk for Chlamydia trachomatis infection, particularly sexually active women under 25 years of age and men who have sex with men.
• Symptomatic Patients Patients presenting with symptoms such as abnormal vaginal discharge, pelvic pain, or urethral discharge, which may suggest a Chlamydia infection.
• Contact Tracing Individuals who have had sexual contact with a confirmed case of Chlamydia trachomatis infection.
• Follow-Up Testing Patients who have been previously treated for Chlamydia trachomatis to confirm the resolution of the infection.

2. Procedure

The procedure for CPT® Code 87320 involves several key steps to ensure accurate detection of Chlamydia trachomatis antigens. The following procedural steps are outlined:

• Step 1: Specimen Collection A specimen is collected from the patient, which may include a cervical, urethral, or rectal swab. The choice of specimen type depends on the patient's symptoms and risk factors. Proper collection techniques are essential to obtain a viable sample for testing.
• Step 2: Sample Preparation The collected specimen is prepared for analysis. This may involve the addition of specific reagents that facilitate the binding of the Chlamydia trachomatis antigens to the antibodies used in the immunoassay.
• Step 3: Immunoassay Technique Application The prepared sample undergoes testing using one of the immunoassay techniques: EIA, ELISA, FIA, or IMCA. Each method employs specific antibodies that bind to the Chlamydia antigens present in the sample. The choice of technique may depend on laboratory capabilities and the required sensitivity of the test.
• Step 4: Detection and Interpretation After the immunoassay is performed, the results are analyzed. For EIA and ELISA, a color change or fluorescence indicates the presence of the antigen, while FIA uses fluorescent compounds for detection. IMCA quantifies the antigen-antibody complex through light emission. The results are then interpreted as either qualitative (positive or negative) or semi-quantitative based on the intensity of the reaction.

3. Post-Procedure

Post-procedure care for patients undergoing testing with CPT® Code 87320 typically involves providing the patient with their test results and any necessary follow-up actions. If the test result is positive, the patient may require further evaluation and treatment for Chlamydia trachomatis infection. Counseling on safe sexual practices and the importance of notifying sexual partners may also be recommended to prevent reinfection and further transmission. In cases of negative results, patients may still be advised to undergo regular screenings, especially if they remain at risk for STIs. Additionally, healthcare providers should document the results and any follow-up plans in the patient's medical record to ensure continuity of care.